Carex’s management team sees Ancor as a great partner for future growth because of Ancor’s proven ability to enhance product development strategies and improve distribution capabilities.
Fort Worth, TX (PRWEB) September 27, 2010
Carex is the market leader of branded home medical equipment sold directly to the consumer through drug store chains, mass merchants, DME dealers and grocery retailers. Carex serves a diversified base of blue-chip and independent retailers who have dramatically increased their shelf space dedicated to home medical products. In addition, Carex offers one of the broadest product lines in the industry, including pain therapy and medication compliance aids. Carex products are also fully stocked in the drug wholesalers who service this retail market.
Randall Keene, Ancor Managing Partner, says, "Carex has the unique opportunity to benefit from the shift in the retail environment to larger big-box retailers and the demographic trends of the baby-boomer generation. Carex has taken major steps toward satisfying the modern consumer by moving away from the smaller, institutional sales channel and moving into the food, drug and mass merchant retail environment. This transaction represents the fourteenth acquisition for Ancor in the health care sector and allows Ancor to combine the skill sets in both the health care and consumer products sectors.”
Carex Health Brands markets its products under the Carex, Apex, Bed Buddy and Thera-Med brands. The Company’s brands have achieved broad customer awareness in the marketplace and are used by home care patients, the mobility challenged, senior citizens and, in many cases, the general public. Matt McElduff, Carex President, states, “Carex’s management team sees Ancor as a great partner for future growth because of Ancor’s proven ability to enhance product development strategies and improve distribution capabilities.”
Ancor Capital Partners, based in Fort Worth, Texas, is an operations-oriented private equity firm focused on lower middle-market manufacturing and distribution companies with EBITDA of $5-$15 million. Extensive operational experience gives the Ancor team a unique understanding of the critical business issues faced by lower middle-market companies.
Ancor’s proven track record includes 26 acquisitions to date in health care, food processing and other industries.
For more information, please contact: Brook M. Smith at bsmith(at)ancorcapital(dot)com.
# # #